Cargando…

Experience With the Use of Rituximab for the Treatment of Rheumatoid Arthritis in a Tertiary Hospital in Spain: RITAR Study

There is evidence supporting that there are no relevant clinical differences between dosing rituximab 1000 mg or 2000 mg per cycle in rheumatoid arthritis (RA) patients in clinical trials, and low-dose cycles seem to have a better safety profile. Our objective was to describe the pattern of use of r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cañamares, Iciar, Merino, Leticia, López, Jorge, Llorente, Irene, García-Vadillo, Alberto, Ramirez, Esther, López-Bote, Juan Pedro, Benedí, Juana, Muñoz-Calleja, Cecilia, Álvaro-Gracia, José M., Castañeda, Santos, González-Álvaro, Isidoro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727960/ https://www.ncbi.nlm.nih.gov/pubmed/30001257 http://dx.doi.org/10.1097/RHU.0000000000000845

Ejemplares similares

Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons
por: Llorente, Irene, et al.
Publicado: (2020)

Cut-Offs and Response Criteria for the Hospital Universitario La Princesa Index (HUPI) and Their Comparison to Widely-Used Indices of Disease Activity in Rheumatoid Arthritis
por: González-Álvaro, Isidoro, et al.
Publicado: (2016)

Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article “Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis” by Bugatti et al.
por: Castañeda, Santos, et al.
Publicado: (2017)

Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients
por: Llorente, Irene, et al.
Publicado: (2017)

Interleukin 15 Levels in Serum May Predict a Severe Disease Course in Patients with Early Arthritis
por: González-Álvaro, Isidoro, et al.
Publicado: (2011)

The Registry of Accredited Companies in the Construction Sector in Spain: An Administrative Instrument for Risk-Prevention Control
por: Romero-Barriuso, Álvaro, et al.
Publicado: (2019)

Rituximab for Rheumatoid Arthritis
por: Cohen, Marc D., et al.
Publicado: (2015)

The Impact of CXCR4 Blockade on the Survival of Rat Brain Cortical Neurons
por: Merino, José Joaquín, et al.
Publicado: (2016)

A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass
por: Ibañez, Monica, et al.
Publicado: (2010)

Difficult-to-treat rheumatoid arthritis (D2T RA): clinical issues at early stages of disease
por: Leon, Leticia, et al.
Publicado: (2023)

Update on the Safety Profile of Tofacitinib in Rheumatoid Arthritis from Clinical Trials to Real-World Studies: A Narrative Review
por: Álvaro-Gracia, Jose María, et al.
Publicado: (2020)

The comparative responsiveness of Hospital Universitario Princesa Index and other composite indices for assessing rheumatoid arthritis activity
por: González-Álvaro, Isidoro, et al.
Publicado: (2019)

Rituximab for the treatment of rheumatoid arthritis: an update
por: Mok, Chi Chiu
Publicado: (2013)

Curricular framework for quantitative studies of information in library science and documentation in Spain
por: REYES BARRAGÁN, MARÍA J., et al.
Publicado: (2003)

Validation of galectin-1 as potential diagnostic biomarker of early rheumatoid arthritis
por: Triguero-Martínez, Ana, et al.
Publicado: (2020)

Social economic costs of COPD in Extremadura (Spain): an observational study
por: Merino, María, et al.
Publicado: (2018)

Effects of Silicon vs. Hydroxytyrosol-Enriched Restructured Pork on Liver Oxidation Status of Aged Rats Fed High-Saturated/High-Cholesterol Diets
por: Santos-López, Jorge A., et al.
Publicado: (2016)

Development and validation of a multivariate predictive model for rheumatoid arthritis mortality using a machine learning approach
por: Lezcano-Valverde, José M., et al.
Publicado: (2017)

Rituximab and its potential for the treatment of rheumatoid arthritis
por: Bryant, Adam, et al.
Publicado: (2006)

Targeted therapies in rheumatoid arthritis: Focus on rituximab
por: Teng, YKO, et al.
Publicado: (2007)

Rituximab therapy in Greek patients with rheumatoid arthritis
por: Tsiakalos, Aristotelis P, et al.
Publicado: (2008)

Seronegative and seropositive rheumatoid arthritis treated with rituximab
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012)

Update on the use of rituximab for intractable rheumatoid arthritis
por: Looney, R John
Publicado: (2009)

Trends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach: analysis of the EMECAR cohort
por: González-Alvaro, Isidoro, et al.
Publicado: (2008)

Rituximab levels are associated with the B cell homeostasis but not with the clinical response in patients with rheumatoid arthritis
por: Díaz-Torné, Cèsar, et al.
Publicado: (2019)

The prevalence of rheumatoid arthritis in Spain
por: Silva-Fernández, Lucía, et al.
Publicado: (2020)

Galectin-1: A Potential Biomarker Differentiating between Early Rheumatoid Arthritis and Spondyloarthritis
por: Triguero-Martínez, Ana, et al.
Publicado: (2022)

Repeated B-cell depletion with rituximab in rheumatoid arthritis
por: Edwards, J, et al.
Publicado: (2003)

Rituximab treatment in rheumatoid arthritis: how does it work?
por: Boumans, Maria JH, et al.
Publicado: (2009)

The Efficacy and Safety of Rituximab in a Patient with Rheumatoid Spondylitis
por: Kobak, Şenol, et al.
Publicado: (2013)

Treatment of Rheumatoid Arthritis with Biologic DMARDS (Rituximab and Etanercept)
por: Gashi, Afrim A., et al.
Publicado: (2014)

Long-term persistence with rituximab in patients with rheumatoid arthritis
por: Oldroyd, Alexander G S, et al.
Publicado: (2018)

Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis
por: Kilic, Levent, et al.
Publicado: (2018)

Carbapenemase-Producing Gram-Negative Bacteria in Andalusia, Spain, 2014–2018
por: López-Hernández, Inmaculada, et al.
Publicado: (2020)

Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study
por: Ortea, Ignacio, et al.
Publicado: (2016)

Health-related quality of life of patients diagnosed with COPD in Extremadura, Spain: results from an observational study
por: Merino, María, et al.
Publicado: (2019)

Neighborhood environmental factors linked to hospitalizations of older people for viral lower respiratory tract infections in Spain: a case-crossover study
por: Álvaro-Meca, Alejandro, et al.
Publicado: (2022)

The PHQ-PD as a Screening Tool for Panic Disorder in the Primary Care Setting in Spain
por: Muñoz-Navarro, Roger, et al.
Publicado: (2016)

Rethinking the Fertility Transition in Rural Aragón (Spain) Using Height Data
por: Marco-Gracia, Francisco J., et al.
Publicado: (2021)

Ultrasound in clinically suspect arthralgia: the role of power Doppler to predict rheumatoid arthritis development
por: Molina Collada, Juan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p4tc18njr93rhre5bj5mlnvec1